7666 — Metis TechBio Share News
0.000.00%
Last trade - 00:00- HK$13.74bn
- HK$13.89bn
- CNY105.00m
HK-listed Metis TechBio climbs on deal with Eli Lilly
Factbox: Major drugmakers turn to China for licensing deals
HK-listed Metis TechBio, Eli Lilly strike drug-delivery deal worth up to $1.1 billion (updated)
Metis TechBio inks up to $1.1 billion deal with Eli Lilly for drug delivery tech
Brief: Metis Techbio Enters Strategic Collaboration With Lilly
Brief: Metis Techbio HY Loss Attributable Rmb153.2 Million
Metis TechBio jumps on Jiangsu Hengrui-tie up on AI formulation platform
Brief: Metis Techbio Says Chong Fu Resigns As CFO
Brief: Metis Techbio Announces Preclinical TCE Licensing Collaboration With Deerfield Of Up To $1.6 Bln
HK-listed Metis TechBio climbs on Boulevard Bio tie-up
Metis TechBio in deal for experimental autoimmune drug worth up to $1.6 billion (updated)
Metis TechBio signs global licensing deal for biologic drug worth up to $1.6 billion
Brief: Metis Techbio Noted Media Report Alleging CSRC Issued Supplemental Information Requests To Company
Metis TechBio, IMPACT Therapeutics shine in Hong Kong debut